Literature DB >> 24436920

Tuberculum sellae meningiomas: surgical technique, visual outcome, and prognostic factors in 51 cases.

Nevo Margalit1, Tal Shahar2, Gal Barkay3, Lior Gonen2, Erez Nossek2, Uri Rozovski4, Anat Kesler5.   

Abstract

Complete tumor resection with preservation or improvement of visual function is the goal of tuberculum sellae meningioma (TSM) treatment. The authors retrospectively reviewed 51 patients treated surgically for TSM between 2003 and 2010, with special attention to surgical technique, visual outcomes, and prognostic factors for treatment outcome. All patients were operated via the lateral subfrontal approach. The cohort mean age and Karnofsky performance status (KPS) on admission was 57.1 ± 13.6 and 84.3 ± 11.7, respectively. The most common presenting sign was visual impairment. The mean tumor size was 29.4 ± 10.7 mm. In 45 of the patients (88.2%), gross total resection was achieved. Improvement and/or preservation of visual acuity and visual field were achieved in 95.9% and 85.3%, respectively. Visual functions on admission were found to be the strongest predictors for postoperative improvement in visual outcome, followed by better KPS on admission, smaller tumor size, and young age. Postoperative neurological complications included cerebrospinal fluid (CSF) leak, meningitis, and postoperative seizures. TSM can be safely operated on through the lateral subfrontal approach. A high percentage of complete tumor resection and excellent visual outcomes are achieved using this technique. Surgical treatment in the early stage of the disease may result in a better visual outcome.

Entities:  

Keywords:  meningioma; optic nerve; surgical technique; visual outcome

Year:  2013        PMID: 24436920      PMCID: PMC3715609          DOI: 10.1055/s-0033-1342920

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  17 in total

1.  The recurrence of intracranial meningiomas after surgical treatment.

Authors:  D SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

2.  Optic canal involvement in tuberculum sellae meningiomas: influence on approach, recurrence, and visual recovery.

Authors:  Mohamed Mahmoud; Remi Nader; Ossama Al-Mefty
Journal:  Neurosurgery       Date:  2010-09       Impact factor: 4.654

3.  Tuberculum sellae meningiomas: clinical outcome considering different surgical approaches.

Authors:  Makoto Nakamura; Florian Roser; Melena Struck; Peter Vorkapic; Madjid Samii
Journal:  Neurosurgery       Date:  2006-11       Impact factor: 4.654

4.  Visual acuities "hand motion" and "counting fingers" can be quantified with the freiburg visual acuity test.

Authors:  Kilian Schulze-Bonsel; Nicolas Feltgen; Hermann Burau; Lutz Hansen; Michael Bach
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

5.  Pterional surgery of meningiomas of the tuberculum sellae and planum sphenoidale: surgical results with special consideration of ophthalmological and endocrinological outcomes.

Authors:  Rudolf Fahlbusch; Werner Schott
Journal:  J Neurosurg       Date:  2002-02       Impact factor: 5.115

6.  Tuberculum sellae meningioma: a report on management on the basis of a surgical experience with 70 patients.

Authors:  Atul Goel; Dattatraya Muzumdar; Ketan I Desai
Journal:  Neurosurgery       Date:  2002-12       Impact factor: 4.654

7.  Tuberculum sellae meningiomas: microsurgical anatomy and surgical technique.

Authors:  George I Jallo; Vallo Benjamin
Journal:  Neurosurgery       Date:  2002-12       Impact factor: 4.654

8.  Meningiomas involving the optic nerve: technical aspects and outcomes for a series of 50 patients.

Authors:  Nevo S Margalit; Jonathan B Lesser; Jason Moche; Chandranath Sen
Journal:  Neurosurgery       Date:  2003-09       Impact factor: 4.654

9.  Tuberculum and diaphragma sella meningioma--surgical technique and visual outcome in a series of 20 cases operated over a 2.5-year period.

Authors:  N Margalit; A Kesler; H Ezer; S Freedman; Z Ram
Journal:  Acta Neurochir (Wien)       Date:  2007-10-29       Impact factor: 2.216

10.  Endoscopic endonasal resection of anterior cranial base meningiomas.

Authors:  Paul A Gardner; Amin B Kassam; Ajith Thomas; Carl H Snyderman; Ricardo L Carrau; Arlan H Mintz; Daniel M Prevedello
Journal:  Neurosurgery       Date:  2008-07       Impact factor: 4.654

View more
  6 in total

1.  Meningiomas of the Planum Sphenoidale and Tuberculum Sella.

Authors:  Elizabeth L Echalier; Prem S Subramanian
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-12

2.  Surgical management of skull base tumors.

Authors:  Leonardo Rangel-Castilla; Jonathan J Russin; Robert F Spetzler
Journal:  Rep Pract Oncol Radiother       Date:  2014-10-14

3.  The endoscopic endonasal approach is not superior to the microscopic transcranial approach for anterior skull base meningiomas-a meta-analysis.

Authors:  Ivo S Muskens; Vanessa Briceno; Tom L Ouwehand; Joseph P Castlen; William B Gormley; Linda S Aglio; Amir H Zamanipoor Najafabadi; Wouter R van Furth; Timothy R Smith; Rania A Mekary; Marike L D Broekman
Journal:  Acta Neurochir (Wien)       Date:  2017-11-10       Impact factor: 2.216

4.  Prognostic factors of microsurgical treatment of intracranial meningiomas - A multivariate analysis.

Authors:  Maika Kreßner; Felix Arlt; Wolf Riepl; Jürgen Meixensberger
Journal:  PLoS One       Date:  2018-10-16       Impact factor: 3.240

5.  Tuberculum Sella Meningioma: Surgical Management and Results with Emphasis on Visual Outcome.

Authors:  Rajneesh Kachhara; Pulak Nigam; Suresh Nair
Journal:  J Neurosci Rural Pract       Date:  2022-06-08

6.  Quality of life and olfactory function after suprasellar craniopharyngioma surgery-a single-center experience comparing transcranial and endoscopic endonasal approaches.

Authors:  Sascha Marx; Ioanna Tsavdaridou; Sebastian Paul; Antje Steveling; Cornelia Schirmer; Marton Eördögh; Stephan Nowak; Marc Matthes; Ehab El Refaee; Steffen K Fleck; Joerg Baldauf; Markus M Lerch; Andreas Stahl; Werner Hosemann; Henry W S Schroeder
Journal:  Neurosurg Rev       Date:  2020-07-10       Impact factor: 3.042

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.